HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages [see comments]

Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.

HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages [see comments]

Nat Med. 1999 Sep;5(9):997-103. Unique Identifier : AIDSLINE MED/99401078
Swingler S; Mann A; Jacque J; Brichacek B; Sasseville VG; Williams K; Lackner AA; Janoff EN; Wang R; Fisher D; Stevenson M; University of Massachusetts Medical Center, Program in Molecular; Medicine, 373 Plantation Street, Worcester, Massachusetts 01605,; USA.

Abstract: Infection of macrophage lineage cells is a feature of primate lentivirus replication, and several properties of primate lentiviruses seem to have evolved to promote the infection of macrophages. Here we demonstrate that the accessory gene product Nef induces the production of two CC-chemokines, macrophage inflammatory proteins 1alpha and 1beta, by HIV-1-infected macrophages. Adenovirus-mediated expression of Nef in primary macrophages was sufficient for chemokine induction. Supernatants from Nef-expressing macrophages induced both the chemotaxis and activation of resting T lymphocytes, permitting productive HIV-1 infection. These results indicate a role for Nef in lymphocyte recruitment and activation at sites of virus replication.

Keywords: JOURNAL ARTICLE Adenoviridae/GENETICS Animal Cell Line Cells, Cultured Chemokines/BIOSYNTHESIS/GENETICS *Chemotaxis/DRUG EFFECTS Culture Media, Conditioned Cytokines/BIOSYNTHESIS Encephalitis, Viral/IMMUNOLOGY/VIROLOGY Gene Products, nef/GENETICS/*PHYSIOLOGY Human HIV-1/DRUG EFFECTS/GROWTH & DEVELOPMENT/GENETICS/*PHYSIOLOGY *Lymphocyte Transformation/DRUG EFFECTS Macaca Macrophage Inflammatory Protein-1/BIOSYNTHESIS/GENETICS Macrophages/IMMUNOLOGY/METABOLISM/*VIROLOGY Mutation Support, Non-U.S. Gov't Support, U.S. Gov't, P.H.S. SIV/DRUG EFFECTS/GROWTH & DEVELOPMENT/PHYSIOLOGY T-Lymphocytes/DRUG EFFECTS/*IMMUNOLOGY/VIROLOGY Virus Replication/DRUG EFFECTS
Comment in: Nat Med 1999 Sep;5(9):985-6
991230
A99C1007

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .